JPMorgan Europe Research Enhanced Index Equity Active (LON:JREE)
London · Delayed Price · Currency is GBP · Price in EUR 55.20
-0.07 (-0.13%)
Jun 18, 2026, 4:35 PM GMT
20.76% (1Y)
| Assets | 2.42B |
| Expense Ratio | 0.25% |
| PE Ratio | 10.22 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +20.76% |
| Volume | 20,369 |
| Open | 55.55 |
| Previous Close | 55.27 |
| Day's Range | 55.05 - 55.55 |
| 52-Week Low | 44.57 |
| 52-Week High | 55.55 |
| Beta | 0.70 |
| Holdings | 158 |
| Inception Date | Oct 10, 2018 |
About JREE
This fund's primary objective is to deliver long-term growth that outperforms the MSCI Europe Index (Total Return Net), its designated benchmark. It accomplishes this by employing an active investment strategy, primarily focusing its capital on a selection of European corporate entities.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol JREE
Provider JPMorgan
Performance
JREE had a total return of 20.76% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.31%.
Top 10 Holdings
23.45% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.54% |
| AstraZeneca PLC | AZN | 2.61% |
| Shell plc | SHEL | 2.38% |
| Siemens Aktiengesellschaft | SIE | 2.22% |
| HSBC Holdings plc | HSBA | 2.15% |
| Nestlé S.A. | NESN | 2.12% |
| Allianz SE | ALV | 2.02% |
| Roche Holding AG | ROP | 1.90% |
| Novartis AG | NOVN | 1.89% |
| Banco Santander, S.A. | SAN | 1.62% |